Harnessing gene power to make
treatment accessible to all
About AnGes
News
All
Development
Product Info
IR
Information
- 2025.10.27IR
- Notice Regarding Revision of Consolidated Earnings Forecast for the Fiscal Year Ending December 2025
- 2025.09.04Development
- Notice of Expansion of License Agreement Scope by Our Subsidiary
- 2025.09.04Development
- Notice Regarding the Initiation of a New Clinical Study for the Jointly Developed Tie2 Receptor Agonist (AV-001)
- 2025.08.26Product Info
- ACRL Announcement on Commencement of Biomarker Testing for Mucopolysaccharidosis
- 2025.08.20Development
- HGF Gene Therapy Product: AnGes and Boehringer Enter Manufacturing Collaboration